Expand IMMP Menu
IMMP MENU

IMMP Latest Press Releases

-- December 16, 2025 --

Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace Globe Newswire 8:00 AM

-- December 8, 2025 --

Immutep and Dr. Reddy's enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa Globe Newswire 8:00 AM

-- December 2, 2025 --

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium Globe Newswire 8:00 AM

-- November 13, 2025 --

Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025 Globe Newswire 8:00 AM

-- November 3, 2025 --

Immutep Receives A$4.6 million R&D Tax Incentive from French Government Globe Newswire 8:00 AM

-- October 29, 2025 --

Immutep Quarterly Activities Report Q1 FY26 Globe Newswire 8:00 AM

-- October 20, 2025 --

Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025 Globe Newswire 8:01 AM
Two Posters at ESMO Congress 2025 Highlight Immutep's Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer Globe Newswire 8:00 AM

-- October 13, 2025 --

Immutep Announces Successful Completion of FDA Project Optimus Requirements Globe Newswire 8:00 AM

-- October 9, 2025 --

Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer Globe Newswire 8:00 AM

-- September 22, 2025 --

Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti Globe Newswire 8:00 AM

-- September 8, 2025 --

Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025 Globe Newswire 8:00 AM

-- July 30, 2025 --

Immutep Quarterly Activities Report Q4 FY25 Globe Newswire 8:00 AM

-- July 29, 2025 --

Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer Globe Newswire 8:00 AM

-- July 28, 2025 --

Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes